A new contract research org, which has been named Lovelace Biomedical by its parent co, launched this week as it seeks new biotech and pharma partners for…

Premier Research has been given what the company is dubbing a “growth investment” from Metalmark Capital, a New York-based private equity firm--although…

IMARC Research, a CRO based in Strongsville, OH, opens a new office in the Minneapolis area in an effort to gain a bigger share of the medical device market.

Actinium Pharmaceuticals has partnered up with Memphis, TN-based CRO Vector Oncology to help it with a midstage study of its experimental blood cancer med…

Building on their 5-year, 2012 endometriosis research deal, and clearly happy with what it has seen, German pharma Bayer has notched another pact with Evotec,…

GE is setting up a new site, to be known as “GE BioPark Cork,” as it looks to boost its off-the-shelf biomanufacturing facilities in Ireland.

Lonza Houston and Massachusetts Eye and Ear, the world’s largest vision and hearing research center, have inked a new pact that will allow gene therapy players…

Apparent Lonza target Catalent has produced an about-face with its buyout of drug development and clinical manufacturing co Pharmatek for an undisclosed sum.

R&D